Philip Toleikis, Sernova CEO

Ser­no­va says five di­a­betes pa­tients have now been tak­en off in­sulin af­ter 'cell pouch' ther­a­py

Five pa­tients with type 1 di­a­betes have stopped tak­ing in­sulin af­ter get­ting Ser­no­va’s cell trans­plant treat­ment, the Cana­di­an biotech re­port­ed Mon­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.